Tuesday, March 04, 2025 | 03:21 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Bayer board backs CEO after unprecedented shareholder rebuke

Baumann suffers defeat with 55% of shareholders in opposition

Bayer
Premium

Bloomberg
Bayer AG’s supervisory board threw its support behind Chief Executive Officer Werner Baumann after an unprecedented shareholder rebuke over his handling of the $63 billion Monsanto deal and the wave of US lawsuits that followed.

At a fractious, 13-hour Annual General Meeting earlier in Bonn, 55.5 percent of shareholders voted against absolving Baumann and other managers of responsibility for their actions in the takeover last year. Though the shock result isn’t legally binding, it prompted an emergency session of the German drugs and chemicals company’s supervisory board that stretched into the early hours of Saturday morning.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in